Related Experiment Videos
Clinical experience with retreatment for palliation.
1Department of Radiation Oncology, the University of North Carolina, Chapel Hill, NC, USA.
Seminars in Radiation Oncology
|October 18, 2000
Summary
Reirradiation can help palliate cancer symptoms but carries risks. This review guides oncologists on the efficacy and toxicity of retreatment to manage normal tissue tolerance.
Area of Science:
- Oncology
- Radiation Oncology
Background:
- Reirradiation is sometimes necessary for palliative cancer care.
- Exceeding normal tissue tolerance is a key concern with reirradiation.
Purpose of the Study:
- To review the literature on reirradiation for palliation.
- To provide clinical guidance on the risks and benefits of retreatment.
Main Methods:
- Literature review of reirradiation studies.
- Analysis of efficacy and toxicity data.
Main Results:
- Information on the efficacy of reirradiation is available.
- Data on the toxicity of reirradiation is crucial for safe practice.
Conclusions:
- Clinicians need guidance on reirradiation risks and benefits.
- Understanding side effects is essential for patient management.